We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Millipore First to Offer Full-length Biologically Relevant mTOR

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Millipore First to Offer Full-length Biologically Relevant mTOR"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

Millipore Corporation has announced the availability of its full-length mTOR kinase as part of the KinaseProfiler™ Service. This kinase is the first biologically relevant mTOR to be commercially available.

The KinaseProfiler Service offers 264 kinases for selectivity profiling, using a catalytic radiometric assay format. The addition of the full-length mTOR to the KinaseProfiler panel provides high-quality, confidential screening of compounds against this critically important kinase.

The mTOR kinase has recently been linked to many important human diseases, including cancer, diabetes, obesity, cardiovascular disease ad neurological disorders. The kinase enables the regulation of cell cycle progression, cell growth, protein synthesis, ribosome biogenesis and autophagy, important target factors in the study of mTOR related diseases.